RESLIN Side Effects

6212227-7 | Cataract, Somnolence
on May 21, 2009 Female patient from JAPAN , 60 years of age, was diagnosed with depression (What is depression?), anxiety disorder and was treated with Reslin (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), somnolence. Reslin dosage: Unk. During the same period patient was treated with LORAMET (Unk) (View Loramet Review and Loramet Label ), WYPAX (Unk) (View Wypax Review and Wypax Label ), TOLEDOMIN (Unk) (View Toledomin Review and Toledomin Label ), SEROQUEL (50 Mg) (View Seroquel Review and Seroquel Label ), MYSLEE (5 Mg) (View Myslee Review and Myslee Label ).

6054731-0 | Inappropriate Antidiuretic Hormone Secretion, Rhabdomyolysis
Patient was taking Reslin (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion, rhabdomyolysis on Jan 22, 2009 from ITALY Additional patient health information: Male patient , 64 years of age, was diagnosed with adjustment disorder, hypertriglyceridaemia, alcoholism (What is alcoholism?) and. Reslin dosage: . During the same period patient was treated with SULPIRIDE (View Sulpiride Review and Sulpiride Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ). Patient was hospitalized.

5939877-7 | Delayed Recovery From Anaesthesia
Adverse event was reported on Oct 24, 2008 by a Female patient taking Reslin (View Usage) (Dosage: ) was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Location: ITALY , 77 years of age, After Reslin was administered, patient had the following side effects: delayed recovery from anaesthesia. During the same period patient was treated with FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), REMIFENTANIL HCL (View Remifentanil Hcl Review and Remifentanil Hcl Label ), MUSCULAX (View Musculax Review and Musculax Label ), NAROPIN (View Naropin Review and Naropin Label ).

5806859-5 | Serotonin Syndrome
on Jul 07, 2008 Female patient from ITALY , 83 years of age, was diagnosed with anxiety disorder and was treated with Reslin (View Usage). Patient experienced the following unwanted or unexpected effects: serotonin syndrome. Reslin dosage: . During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ), RISPERIDONE (Dose Was Decreased To 0.5 Mg And Again Increased To 1 Mg) (View Risperidone Review and Risperidone Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.


5656557-6 | Coma, Suicide Attempt
on Mar 04, 2008 Female patient from ITALY , 20 years of age, was treated with Reslin (View Usage). Patient had the following side effects: coma, suicide attempt. Reslin dosage: . During the same period patient was treated with LENDORMIN (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

5653630-3 | Altered State Of Consciousness, Delirium
Patient was taking Reslin (View Usage). After Reslin was administered, patient had the following side effects: altered state of consciousness, delirium on Feb 18, 2008 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with delirium, insomnia and. Reslin dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

5577611-3 | Ventouse Extraction
Adverse event was reported on Dec 21, 2007 by a Female patient taking Reslin (View Usage) (Dosage: 25 Mg, Tid) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 28 years of age, Patient experienced the following unwanted or unexpected effects: ventouse extraction. During the same period patient was treated with AMOXAPINE (25 Mg, Tid) (View Amoxapine Review and Amoxapine Label ), SOLANAX (0.4 Mg, Qd) (View Solanax Review and Solanax Label ), TOFRANIL (25 Mg, Tid) (View Tofranil Review and Tofranil Label ). Patient was hospitalized.

5572971-1 | Agranulocytosis, Pancytopenia, Septic Shock
on Dec 13, 2007 Male patient from ITALY , 79 years of age, was diagnosed with depression (What is depression?), anorexia, anxiety (What is anxiety?) and was treated with Reslin (View Usage). Patient had the following side effects: agranulocytosis, pancytopenia, septic shock. Reslin dosage: . During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), PAXIL (View Paxil Review and Paxil Label ).

5507429-9 | Pancytopenia
on Nov 05, 2007 Male patient from ITALY , 79 years of age, was diagnosed with depression (What is depression?) and was treated with Reslin (View Usage). After Reslin was administered, patient had the following side effects: pancytopenia. Reslin dosage: . During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), PAXIL (View Paxil Review and Paxil Label ), MEILAX (View Meilax Review and Meilax Label ), DEPAS (View Depas Review and Depas Label ).

5429103-X | Altered State Of Consciousness, Thirst
Patient was taking Reslin (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, thirst on Aug 10, 2007 from ITALY Additional patient health information: Male patient , 62 years of age, was diagnosed with depression (What is depression?) and. Reslin dosage: . Patient was hospitalized.

5406996-3 | Neuroleptic Malignant Syndrome, Quadriplegia, Renal Failure Acute, Suicide Attempt
Adverse event was reported on Aug 03, 2007 by a Male patient taking Reslin (View Usage) (Dosage: ) was diagnosed with depression (What is depression?), insomnia and. Location: JAPAN , 44 years of age, Patient had the following side effects: neuroleptic malignant syndrome, quadriplegia, renal failure acute, suicide attempt. During the same period patient was treated with TRIAZOLAM (View Triazolam Review and Triazolam Label ), CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), TANDOSPIRONE CITRATE (View Tandospirone Citrate Review and Tandospirone Citrate Label ), RILMAZAFONE HCL (View Rilmazafone Hcl Review and Rilmazafone Hcl Label ). Patient was hospitalized.

5406931-8 | Delirium, Neuroleptic Malignant Syndrome, Quadriplegia, Renal Failure Acute
on Aug 03, 2007 Male patient from JAPAN , 59 years of age, was diagnosed with depression (What is depression?), schizophrenia, parkinsonism, orthostatic hypotension and was treated with Reslin (View Usage). After Reslin was administered, patient had the following side effects: delirium, neuroleptic malignant syndrome, quadriplegia, renal failure acute. Reslin dosage: . During the same period patient was treated with LUDIOMIL (View Ludiomil Review and Ludiomil Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), TRYPTANOL (View Tryptanol Review and Tryptanol Label ), PERPHENAZINE (View Perphenazine Review and Perphenazine Label ), DEPAS (View Depas Review and Depas Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), RISUMIC (View Risumic Review and Risumic Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ). Patient was hospitalized.

5355423-3 | Platelet Count Decreased, White Blood Cell Count Decreased
on Jun 05, 2007 Female patient from ITALY , 80 years of age, was treated with Reslin (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased, white blood cell count decreased. Reslin dosage: . Patient was hospitalized.

5240562-8 | Neuroleptic Malignant Syndrome, Renal Failure Acute, Suicide Attempt
Patient was taking Reslin (View Usage). Patient had the following side effects: neuroleptic malignant syndrome, renal failure acute, suicide attempt on Feb 05, 2007 from JAPAN Additional patient health information: Male patient , 44 years of age, . Reslin dosage: . During the same period patient was treated with TRIAZOLAM (View Triazolam Review and Triazolam Label ), CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), TANDOSPIRONE CITRATE (View Tandospirone Citrate Review and Tandospirone Citrate Label ), RILMAZAFONE HCL (View Rilmazafone Hcl Review and Rilmazafone Hcl Label ). Patient was hospitalized.

5239337-5 | Delirium, Neuroleptic Malignant Syndrome, Renal Failure Acute
Adverse event was reported on Feb 05, 2007 by a Male patient taking Reslin (View Usage) (Dosage: ) . Location: JAPAN , 49 years of age, After Reslin was administered, patient had the following side effects: delirium, neuroleptic malignant syndrome, renal failure acute. During the same period patient was treated with MAPROTILINE HCL (View Maprotiline Hcl Review and Maprotiline Hcl Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ). Patient was hospitalized.

5176440-2 | Coma, Neuroleptic Malignant Syndrome, Suicide Attempt
on Sep 26, 2006 Female patient from ITALY , 21 years of age, was treated with Reslin (View Usage). Patient experienced the following unwanted or unexpected effects: coma, neuroleptic malignant syndrome, suicide attempt. Reslin dosage: . During the same period patient was treated with LIMAS (View Limas Review and Limas Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5163892-7 | Pulmonary Thrombosis
on Nov 12, 2006 Male patient from ITALY , 52 years of age, was diagnosed with insomnia, alcoholic psychosis and was treated with Reslin (View Usage). Patient had the following side effects: pulmonary thrombosis. Reslin dosage: . During the same period patient was treated with VEGETAMIN (View Vegetamin Review and Vegetamin Label ), LULLAN (View Lullan Review and Lullan Label ), EURODIN (View Eurodin Review and Eurodin Label ), MEILAX (View Meilax Review and Meilax Label ), AMOBAN (View Amoban Review and Amoban Label ), ROHIPNOL (View Rohipnol Review and Rohipnol Label ), LODOPIN (View Lodopin Review and Lodopin Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

5150607-1 | Self Injurious Behaviour
Patient was taking Reslin (View Usage). After Reslin was administered, patient had the following side effects: self injurious behaviour on Oct 16, 2006 from JAPAN Additional patient health information: Female patient , 26 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Reslin dosage: . During the same period patient was treated with SOLANAX (24/7/06-30/7/06 .800 Mg Qd,31/7/06-20/8/06 .400 Mg, 21/8/06-cont .800 Mg 10/7-23/7/06 1.200 Mg) (View Solanax Review and Solanax Label ), ZOLOFT (10/7/06-17/7/06 50 Mg Qd, 18/7/06-23/7/06 75 Mg Qd, 24/7/06-20/8/06 100 Mg Qd) (View Zoloft Review and Zoloft Label ), DEPAS (View Depas Review and Depas Label ), MYSLEE (View Myslee Review and Myslee Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

5128932-X | Liver Disorder, Systemic Lupus Erythematosus
Adverse event was reported on Sep 27, 2006 by a Female patient taking Reslin (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder, systemic lupus erythematosus. During the same period patient was treated with SULPIRIDE (View Sulpiride Review and Sulpiride Label ), XANAX (View Xanax Review and Xanax Label ), TOLAZOLINE HCL (View Tolazoline Hcl Review and Tolazoline Hcl Label ). Patient was hospitalized.

5123902-X | Neuroleptic Malignant Syndrome
on Sep 26, 2006 Female patient from JAPAN , 21 years of age, was treated with Reslin (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Reslin dosage: . During the same period patient was treated with LIMAS (View Limas Review and Limas Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

4975645-0 | Neuroleptic Malignant Syndrome
on Feb 28, 2006 Male patient from ITALY , 79 years of age, was treated with Reslin (View Usage). After Reslin was administered, patient had the following side effects: neuroleptic malignant syndrome. Reslin dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

4944383-2 | Anxiety, Dyspnoea, Hyperhidrosis, Hypovolaemic Shock, Supraventricular Tachycardia
Patient was taking Reslin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dyspnoea, hyperhidrosis, hypovolaemic shock, supraventricular tachycardia on Dec 19, 2005 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with depression (What is depression?) and. Reslin dosage: . During the same period patient was treated with TOFRANIL (View Tofranil Review and Tofranil Label ), FLIVAS (View Flivas Review and Flivas Label ), PIMENOL (View Pimenol Review and Pimenol Label ), BLOPRESS (View Blopress Review and Blopress Label ), NORVASC (View Norvasc Review and Norvasc Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), ADETPHOS (View Adetphos Review and Adetphos Label ), ACECOL (View Acecol Review and Acecol Label ). Patient was hospitalized.

4741406-0 | Completed Suicide
Adverse event was reported on Jul 29, 2005 by a Female patient taking Reslin (View Usage) (Dosage: ) . Location: ITALY , 25 years of age, Patient had the following side effects: completed suicide. During the same period patient was treated with MIGSIS (View Migsis Review and Migsis Label ), HALCION (View Halcion Review and Halcion Label ).

4723900-1 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased
on Jun 10, 2005 Male patient from ITALY , 58 years of age, was diagnosed with insomnia, gastritis, hyperlipidaemia and was treated with Reslin (View Usage). After Reslin was administered, patient had the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased. Reslin dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ), LIPOVAS (View Lipovas Review and Lipovas Label ), AMOBAN (View Amoban Review and Amoban Label ), GASLON N (View Gaslon N Review and Gaslon N Label ), DIART (View Diart Review and Diart Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), PARACLODIN (View Paraclodin Review and Paraclodin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ). Patient was hospitalized.

4696925-2 | Blood Creatine Phosphokinase Increased
on Jun 10, 2005 Male patient from , 58 years of age, was diagnosed with depression (What is depression?), insomnia and was treated with Reslin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Reslin dosage: . During the same period patient was treated with AMOBAN (View Amoban Review and Amoban Label ), TAKEPRON (View Takepron Review and Takepron Label ), GASLON N (View Gaslon N Review and Gaslon N Label ), LIPOVAS (View Lipovas Review and Lipovas Label ), DIART (View Diart Review and Diart Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ). Patient was hospitalized.

4647425-7 | Leukopenia, Pneumonia
Patient was taking Reslin (View Usage). Patient had the following side effects: leukopenia, pneumonia (What is pneumonia?) on Apr 20, 2005 from Additional patient health information: Male patient , 46 years of age, . Reslin dosage: . During the same period patient was treated with ROHYPNOL (View Rohypnol Review and Rohypnol Label ), EVAMYL (View Evamyl Review and Evamyl Label ). Patient was hospitalized.

4641149-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Cholesterol Increased, Liver Disorder
Adverse event was reported on Apr 12, 2005 by a Male patient taking Reslin (View Usage) (Dosage: ) was diagnosed with depression (What is depression?), insomnia, oesophagitis and. Location: , 46 years of age, After Reslin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, liver disorder. During the same period patient was treated with QUAZEPAM (View Quazepam Review and Quazepam Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), MILNACIPRAN (View Milnacipran Review and Milnacipran Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), TELITHROMYCIN (View Telithromycin Review and Telithromycin Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).